Informações de Pulmonx Corp

Mais detalhes de Pulmonx Corp Empresa

Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its solutions, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients. The StratX Platform is a cloud-based quantitative CT analysis service that offers physicians with a report that is designed for its solution, which includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation and has been validated in multiple randomized controlled clinical trials.



Código da empresaLUNG

Nome da EmpresaPulmonx Corp

Data de listagemOct 01, 2020

CEOMr. Steven S. (Steve) Williamson

Número de funcionários291

Tipo de títulosOrdinary Share

Fim do ano fiscalOct 01

Endereço700 Chesapeake Dr

CidadeREDWOOD CITY

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal94063

Telefone16509342600

Sitehttps://pulmonx.com/

Código da empresaLUNG

Data de listagemOct 01, 2020

CEOMr. Steven S. (Steve) Williamson

Executivos da empresa Pulmonx Corp



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Geoffrey Beran Rose

Chief Commercial Officer

230.51K

-2.76%

Mr. Daniel P. (Dan) Florin

Independent Director

102.02K

+145.58%

Mr. Richard M. (Rich) Ferrari

Independent Director

71.81K

+68.35%

Ms. Tiffany Sullivan

Independent Director

59.98K

+162.74%

Mr. Thomas William Burns

Independent Director

58.18K

+176.67%

Mr. Glendon E. (Glen) French

President, Chief Executive Officer, Director

--

Dr. Derrick Sung, Ph.D.

Chief Financial Officer, Chief Operating Officer

--

Mr. Brian Johnston

Investor Relations

--

Mr. David A. Lehman

General Counsel

--

Ms. Georgia Garinoismelenikiotou

Independent Director

--

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Geoffrey Beran Rose

Chief Commercial Officer

230.51K

-2.76%

Mr. Daniel P. (Dan) Florin

Independent Director

102.02K

+145.58%

Mr. Richard M. (Rich) Ferrari

Independent Director

71.81K

+68.35%

Ms. Tiffany Sullivan

Independent Director

59.98K

+162.74%

Mr. Thomas William Burns

Independent Director

58.18K

+176.67%

Mr. Glendon E. (Glen) French

President, Chief Executive Officer, Director

--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Sem dados

Por RegiãoUSD

Nome

Receita

Proporção

United States

14.73M

61.74%

Europe, Middle-East and Africa ("EMEA")

7.00M

29.33%

Asia Pacific

2.03M

8.50%

Other International

102.00K

0.43%

Por Empresa

Por Região

Sem dados

Distribuição de ações

Atualizado em: dom, 17 de ago

Investidores

Tipos de investidores

Investidores

Proporção

PRIMECAP Management Company

12.68%

Fidelity Management & Research Company LLC

10.38%

Morgan Stanley & Co. LLC

7.20%

BlackRock Institutional Trust Company, N.A.

6.01%

The Vanguard Group, Inc.

5.63%

Outro

58.10%

Investidores

Proporção

PRIMECAP Management Company

12.68%

Fidelity Management & Research Company LLC

10.38%

Morgan Stanley & Co. LLC

7.20%

BlackRock Institutional Trust Company, N.A.

6.01%

The Vanguard Group, Inc.

5.63%

Outro

58.10%

Tipos de investidores

Investidores

Proporção

Investment Advisor

46.71%

Hedge Fund

18.86%

Investment Advisor/Hedge Fund

13.06%

Research Firm

9.96%

Individual Investor

4.08%

Sovereign Wealth Fund

0.37%

Pension Fund

0.23%

Bank and Trust

0.18%

Venture Capital

0.14%

Outro

6.41%

Participação acionária institucional



Atualizado em: dom, 5 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

281

36.47M

89.51%

-6.01M

2025Q2

287

39.76M

97.74%

-2.93M

2025Q1

296

39.33M

97.70%

-4.34M

2024Q4

300

39.10M

98.27%

-6.73M

2024Q3

306

39.39M

100.59%

-8.60M

2024Q2

305

38.59M

99.39%

-11.14M

2024Q1

300

38.64M

99.54%

-10.45M

2023Q4

294

37.11M

96.84%

-10.90M

2023Q3

296

35.84M

94.15%

-16.29M

2023Q2

300

36.45M

96.58%

-16.49M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

PRIMECAP Management Company

5.16M

12.68%

-250.08K

-4.62%

Jun 30, 2025

Fidelity Management & Research Company LLC

4.23M

10.38%

-483.02K

-10.25%

Jun 30, 2025

Morgan Stanley & Co. LLC

2.94M

7.2%

+7.85K

+0.27%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

2.45M

6.01%

-88.33K

-3.48%

Jun 30, 2025

The Vanguard Group, Inc.

2.29M

5.63%

+11.68K

+0.51%

Jun 30, 2025

Deerfield Management Company, L.P.

1.89M

4.64%

--

Jun 30, 2025

BNP Paribas Asset Management USA, Inc.

1.17M

2.87%

-83.35K

-6.66%

Jun 30, 2025

Millennium Management LLC

1.17M

2.86%

+958.05K

+459.54%

Jun 30, 2025

DWS Investments UK Limited

1.13M

2.76%

-6.19K

-0.55%

Jun 30, 2025

Silvercrest Asset Management Group LLC

930.56K

2.28%

--

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: há 7 horas

Nome

Proporção

iShares Micro-Cap ETF

0.01%

Proshares Ultra Russell 2000

0%

iShares Russell 2000 Growth ETF

0%

Avantis US Equity ETF

0%

iShares Core S&P Total U.S. Stock Market ETF

0%

Global X Russell 2000 ETF

0%

Schwab U.S. Broad Market ETF

0%

SPDR S&P Health Care Equipment ETF

0%

Invesco Russell 2000 Dynamic Multifactor ETF

0%

Avantis US Small Cap Equity ETF

0%

Ver Mais

iShares Micro-Cap ETF

Proporção0.01%

Proshares Ultra Russell 2000

Proporção0%

iShares Russell 2000 Growth ETF

Proporção0%

Avantis US Equity ETF

Proporção0%

iShares Core S&P Total U.S. Stock Market ETF

Proporção0%

Global X Russell 2000 ETF

Proporção0%

Schwab U.S. Broad Market ETF

Proporção0%

SPDR S&P Health Care Equipment ETF

Proporção0%

Invesco Russell 2000 Dynamic Multifactor ETF

Proporção0%

Avantis US Small Cap Equity ETF

Proporção0%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados